Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Telo Genomics Corp (TELO.VN)

Telo Genomics Corp (TELO.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 5,022
  • Shares Outstanding, K 100,430
  • Annual Sales, $ 0 K
  • Annual Income, $ -2,719 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -0.50
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.03
  • Most Recent Earnings $-0.01 on 11/25/25
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING TSX Diagnostics & Research

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.045 +11.11%
on 01/14/26
0.060 -16.67%
on 12/29/25
unch (unch)
since 12/16/25
3-Month
0.045 +11.11%
on 01/14/26
0.095 -47.37%
on 11/14/25
-0.015 (-23.08%)
since 10/15/25
52-Week
0.045 +11.11%
on 01/14/26
0.160 -68.75%
on 01/23/25
-0.055 (-52.38%)
since 01/15/25

Most Recent Stories

More News
Telo Genomics Launches Retrospective Blood-Based MRD Study with University of Athens as Part of 2026 Multi-Center Validation Program

Toronto, Ontario--(Newsfile Corp. - December 18, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in diagnostic and prognostic innovation through advanced telomere...

TDSGF : 0.0347 (-25.05%)
TELO.VN : 0.050 (+11.11%)
Telo Genomics Presents Genomic Profiles of Peripheral Blood Minimal Residual Disease Cells at the 67th American Society of Hematology Meeting

Toronto, Ontario--(Newsfile Corp. - December 11, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human...

TDSGF : 0.0347 (-25.05%)
TELO.VN : 0.050 (+11.11%)
Telo Genomics to Present Groundbreaking Individual-Cell Risk Assessment MRD Technology at the Myeloma Canada MRD Implementation Summit 2025

Toronto, Ontario--(Newsfile Corp. - November 13, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) ("Telo" or the "Company"), a leader in diagnostic and prognostic innovation through its proprietary...

TDSGF : 0.0347 (-25.05%)
TELO.VN : 0.050 (+11.11%)
Upcoming Meeting Dates - October 13, 2025

Toronto, Ontario--(Newsfile Corp. - October 13, 2025) -  The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies...

NOBL.VN : 0.190 (-13.64%)
SKP.VN : 0.195 (+11.43%)
HTRC.CN : 0.2300 (+21.05%)
CAD.VN : 2.790 (+7.72%)
OTEX.TO : 42.02 (-2.21%)
DGX.VN : 4.420 (+5.49%)
LCX.VN : 0.790 (+1.28%)
ROK.VN : 0.200 (unch)
HCC.VN : 0.010 (unch)
JJ.VN : 0.080 (unch)
ACS.VN : 0.160 (unch)
KLM.VN : 0.005 (unch)
American Society of Hematology Accepts Telo Genomics' Abstract for Presentation at its 2025 Meeting and Exposition

Recognition highlights commercial potential of Telo's telomere-based MRD technology in the growing precision oncology marketToronto, Ontario--(Newsfile Corp. - October 9, 2025) - Telo Genomics Corp. (TSXV:...

TDSGF : 0.0347 (-25.05%)
TELO.VN : 0.050 (+11.11%)
Telo Genomics Expands Operations with Relocation of Clinical Laboratories to New, Larger Toronto Facility and Provides Board Update

Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo"), a leader in the development of diagnostic and prognostic tests for human...

TDSGF : 0.0347 (-25.05%)
TELO.VN : 0.050 (+11.11%)
Telo Geonomics Announces Engagement of Investor Relations Service Provider

Vancouver, British Columbia--(Newsfile Corp. - September 8, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") announces that it has engaged Hayden IR, LLC. ("Hayden"),...

TDSGF : 0.0347 (-25.05%)
TELO.VN : 0.050 (+11.11%)
Telo Genomics to Present at the OTCQB Venture Virtual Investor Conference

Toronto, Ontario--(Newsfile Corp. - August 5, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human...

TDSGF : 0.0347 (-25.05%)
TELO.VN : 0.050 (+11.11%)
International Myeloma Society Accepts Telo Genomics' MRD Abstract for Presentation at Its 2025 Meeting

Toronto, Ontario--(Newsfile Corp. - July 24, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo") a leader in the development of diagnostic and prognostic tests for human disease...

TDSGF : 0.0347 (-25.05%)
TELO.VN : 0.050 (+11.11%)
Telo Genomics Corp. to File Statement of Defence and Counterclaim to Lawsuit Filed by Former President

Toronto, Ontario--(Newsfile Corp. - June 30, 2025) - Telo Genomics Corp. (TSXV: TELO) (OTCQB: TDSGF) (the "Company" or "Telo Genomics") has received a Statement of Claim filed by Sherif Louis, the former...

TDSGF : 0.0347 (-25.05%)
TELO.VN : 0.050 (+11.11%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in developing diagnostic and prognostic products that may save lives, improve the quality of life, and reduce the cost of care associated with numerous diseases that display genomic instability....

See More

Key Turning Points

3rd Resistance Point 0.050
2nd Resistance Point 0.050
1st Resistance Point 0.050
Last Price 0.050
1st Support Level 0.050
2nd Support Level 0.050
3rd Support Level 0.050

See More

52-Week High 0.160
Fibonacci 61.8% 0.116
Fibonacci 50% 0.102
Fibonacci 38.2% 0.089
Last Price 0.050
52-Week Low 0.045

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar